{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:49:33Z","timestamp":1776142173525,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00467-020-04558-8","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T16:03:37Z","timestamp":1588608217000},"page":"1707-1718","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The use of cinacalcet after pediatric renal transplantation: an international CERTAIN Registry analysis"],"prefix":"10.1007","volume":"35","author":[{"given":"Julie","family":"Bernardor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus Peter","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Laure","family":"Sellier-Leclerc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"B\u00fcscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Dello Strologo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurkan","family":"Genc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Zirngibl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Krupka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhard","family":"T\u00f6nshoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine","family":"Bacchetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"4558_CR1","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.2215\/CJN.04331206","volume":"3","author":"SM Moe","year":"2008","unstructured":"Moe SM, Dr\u00fceke T (2008) Improving global outcomes in mineral and bone disorders. Clin J Am Soc Nephrol 3:S127\u2013S130. https:\/\/doi.org\/10.2215\/CJN.04331206","journal-title":"Clin J Am Soc Nephrol"},{"key":"4558_CR2","doi-asserted-by":"publisher","unstructured":"Bacchetta J, Harambat J, Cochat P, Salusky IB, Wesseling-Perry K (2012) The consequences of chronic kidney disease on bone metabolism and growth in children. Nephrol Dial Transplant 27:3063\u20133071. https:\/\/doi.org\/10.1093\/ndt\/gfs299","DOI":"10.1093\/ndt\/gfs299"},{"key":"4558_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"DC Wheeler","year":"2017","unstructured":"Wheeler DC, Winkelmayer WC (2017) KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) foreword. Kidney Int Suppl 7:1\u201359","journal-title":"Kidney Int Suppl"},{"key":"4558_CR4","doi-asserted-by":"publisher","unstructured":"Sohn WY, Portale AA, Salusky IB, Zhang H, Yan LL, Ertik B, Shahinfar S, Lee E, Dehmel B, Warady BA (2019) An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to <\u20096 years with chronic kidney disease receiving dialysis. Pediatr Nephrol 34:145\u2013154. https:\/\/doi.org\/10.1007\/s00467-018-4054-8","DOI":"10.1007\/s00467-018-4054-8"},{"key":"4558_CR5","doi-asserted-by":"publisher","unstructured":"Bacchetta J, Schmitt CP, Ariceta G, Bakkaloglu SA, Groothoft J, Wan M, Vervloet M, Shroff R, Haffner D, on belhalf of the European Society for Paediatric Nephrology and the Chronic Kidney Disease-Mineral and Bone Disorders and Dialysis Working Group of the ERA-EDTA (2020) Cinacalcet use in paediatric dialysis: a position statement from the European Society for Paediatric Nephrology and the Chronic Kidney Disease-Mineral and Bone Disorders Working Group of the ERA-EDTA. Nephrol Dial Transplant 35:47\u201364. https:\/\/doi.org\/10.1093\/ndt\/gfz159","DOI":"10.1093\/ndt\/gfz159"},{"key":"4558_CR6","doi-asserted-by":"publisher","unstructured":"Serra AL, Savoca R, Huber AR, Hepp U, Delsignore A, Hersberger M, W\u00fcthrich RP (2007) Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients. Nephrol Dial Transplant 22:577\u2013583. https:\/\/doi.org\/10.1093\/ndt\/gfl560","DOI":"10.1093\/ndt\/gfl560"},{"key":"4558_CR7","doi-asserted-by":"publisher","unstructured":"El-Amm J-M, Doshi MD, Singh A, Migdal S, Moranwski K, Sternbauer D, Cincotta E, West MS, Losanoff JE, Gruber SA (2007) Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation. Transplantation 83:546\u2013549. https:\/\/doi.org\/10.1097\/01.tp.0000253429.33198.2f","DOI":"10.1097\/01.tp.0000253429.33198.2f"},{"key":"4558_CR8","doi-asserted-by":"publisher","unstructured":"G\u00f3mez Marqu\u00e9s G, Obrador Mulet A, Vilar Gimeno A, Pascual Felip MJ, Alarcon Zurita A, Molina Guasch M, Uriol Rivera M, Losada Gonzalez P (2009) Treatment with cinacalcet of secondary hyperparathyroidism after renal transplantation. Transplant Proc 41:2139\u20132143. https:\/\/doi.org\/10.1016\/j.transproceed.2009.06.090","DOI":"10.1016\/j.transproceed.2009.06.090"},{"key":"4558_CR9","doi-asserted-by":"publisher","unstructured":"Copley JB, Germain M, Stern L,Pankewcz O, Katznelson S, Shah T, Wang O, Turner SA, Sprague SM (2010) Evaluation of cinacalcet HCl treatment after kidney transplantation. Transplant Proc 42:2503\u20132508. https:\/\/doi.org\/10.1016\/j.transproceed.2010.04.052","DOI":"10.1016\/j.transproceed.2010.04.052"},{"key":"4558_CR10","doi-asserted-by":"publisher","unstructured":"Cho ME, Duan Z, Chamberlain CE, Reynols JC, Ring MS, Mannon RB (2010) Cinacalcet improves bone density in post-kidney transplant hyperparathyroidism. Transplant Proc 42:3554\u20133558. https:\/\/doi.org\/10.1016\/j.transproceed.2010.06.027","DOI":"10.1016\/j.transproceed.2010.06.027"},{"key":"4558_CR11","doi-asserted-by":"publisher","unstructured":"Courbebaisse M, Diet C, Timsit M-O, Mamzer MF, Thervet E, Noel LH, Legendre C, Friedlnder G, Martinez F, Pri\u00e9 D (2012) Effects of cinacalcet in renal transplant patients with hyperparathyroidism. Am J Nephrol 35:341\u2013348. https:\/\/doi.org\/10.1159\/000337526","DOI":"10.1159\/000337526"},{"key":"4558_CR12","doi-asserted-by":"publisher","unstructured":"Paschoalin RP, Torregrosa J-V, S\u00e1nchez-Escuredo A, Barros X, Duran CE, Campistol JM (2012) Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up. Transplant Proc 44:2588\u20132589. https:\/\/doi.org\/10.1016\/j.transproceed.2012.09.049","DOI":"10.1016\/j.transproceed.2012.09.049"},{"key":"4558_CR13","doi-asserted-by":"publisher","unstructured":"Torregrosa JV, Morales E, D\u00edaz JM, Crespo J, Bravo J, Gomez G, Gentil MA, Rodriguez-Benot A, Rodriguez-Garcia M, Lopez-Jimenez V, Guti\u00e9rrez-Dalmau A, Jimeno L, P\u00e9rez-Saez MJ, Romero R, Gomez-Alamillo C, Grupo de Estudio CINAREN\u00a0 (2014) Cinacalcet in the management of normocalcaemic secondary hyperparathyroidism after kidney transplantation: one-year follow-up multicentre study. Nefrologia 34:62\u201368. https:\/\/doi.org\/10.3265\/Nefrologia.pre2013.Aug.12183","DOI":"10.3265\/Nefrologia.pre2013.Aug.12183"},{"key":"4558_CR14","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.transproceed.2016.01.044","volume":"48","author":"E Wa\u017cna-Jab\u0142o\u0144ska","year":"2016","unstructured":"Wa\u017cna-Jab\u0142o\u0144ska E, Ga\u0142\u0105zka Z, Durlik M (2016) Treatment of persistent hypercalcemia and hyperparathyroidism with cinacalcet after successful kidney transplantation. Transplant Proc 48:1623\u20131625. https:\/\/doi.org\/10.1016\/j.transproceed.2016.01.044","journal-title":"Transplant Proc"},{"key":"4558_CR15","doi-asserted-by":"publisher","unstructured":"Soliman AR, Maamoun HA, Soliman MA, Daewish H, Elbanna E (2016) Cinacalcet versus parathyroidectomy in the treatment of secondary hyperparathyroidism post renal transplantation. Rom J Intern Med 54:184\u2013189. https:\/\/doi.org\/10.1515\/rjim-2016-0027","DOI":"10.1515\/rjim-2016-0027"},{"key":"4558_CR16","doi-asserted-by":"publisher","unstructured":"Mawad H, Bouchard H, Tran D, Ouimet D, Lafrance JP, Bell RB, Bezzaoucha S, Boucher A, Collette S, Pichette V, Sen\u00e9cal L, Vall\u00e9e M (2017) Retrospective study looking at cinacalcet in the management of hyperparathyroidism after kidney transplantation. J Transp Secur 2017. https:\/\/doi.org\/10.1155\/2017\/8720283","DOI":"10.1155\/2017\/8720283"},{"key":"4558_CR17","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/ndt\/gfh924","volume":"20","author":"AE Kruse","year":"2005","unstructured":"Kruse AE, Eisenberger U, Frey FJ, Mohaupt MG (2005) The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant 20:1311\u20131314. https:\/\/doi.org\/10.1093\/ndt\/gfh924","journal-title":"Nephrol Dial Transplant"},{"key":"4558_CR18","doi-asserted-by":"publisher","unstructured":"Apostolou T, Kollia K, Damianou L, Kaitsioti H, Kotsiev V, Dracopoulos S, Vougas V, Hadjiconstantinou V (2006) Hypercalcemia due to resistant hyperparathyroidism in renal transplant patients treated with the calcimimetic agent cinacalcet. Transplant Proc 38:3514\u20133516. https:\/\/doi.org\/10.1016\/j.transproceed.2006.10.133","DOI":"10.1016\/j.transproceed.2006.10.133"},{"key":"4558_CR19","doi-asserted-by":"publisher","unstructured":"Kamar N, Gennero I, Spataru L, Esposito L, Guitard J, Lavayssi\u00e8re L, Cointault O, Gandia O, Durand D, Rostaing L (2008) Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose. Nephrol Dial Transplant 23:3720\u20133726. https:\/\/doi.org\/10.1093\/ndt\/gfn345","DOI":"10.1093\/ndt\/gfn345"},{"key":"4558_CR20","doi-asserted-by":"publisher","unstructured":"Bergua C, Torregrosa J-V, Fuster D, Gutierrez-Dalmau A, Oppenheimer F, Campistol JM (2008) Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism. Transplantation 86:413\u2013417. https:\/\/doi.org\/10.1097\/TP.0b013e31817c13e1","DOI":"10.1097\/TP.0b013e31817c13e1"},{"key":"4558_CR21","doi-asserted-by":"publisher","unstructured":"Borchhardt KA, Heinzl H, Mayerw\u00f6ger E, H\u00f6rl WH, Haas M, Sunder-Plassmann G (2008) Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation. Transplantation 86:919\u2013924. https:\/\/doi.org\/10.1097\/TP.0b013e318186b7fb","DOI":"10.1097\/TP.0b013e318186b7fb"},{"key":"4558_CR22","doi-asserted-by":"publisher","unstructured":"Serra AL, Wuhrmann C, W\u00fcthrich RP (2008) Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism. Am J Kidney Dis 52:1151\u20131157. https:\/\/doi.org\/10.1053\/j.ajkd.2008.08.012","DOI":"10.1053\/j.ajkd.2008.08.012"},{"key":"4558_CR23","doi-asserted-by":"publisher","unstructured":"Carrasco FR, P\u00e9rez-Flores I, Calvo N, Ridao A, Sanchez A, Barrientos A (2009) Treatment of persistent hyperparathyroidism in renal transplant patients with cinacalcet improves control of blood pressure. Transplant Proc 41:2385\u20132387. https:\/\/doi.org\/10.1016\/j.transproceed.2009.06.167","DOI":"10.1016\/j.transproceed.2009.06.167"},{"key":"4558_CR24","doi-asserted-by":"publisher","unstructured":"L\u00f3pez V, Toledo R, Sola E, Gutti\u00e9rrez C, Sujan S, Rodriguez MA, Cabello M, Burgos D, Gonzalez Molina M, Hernandez D (2009) Treatment with cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism. Transplant Proc 41:2394\u20132395. https:\/\/doi.org\/10.1016\/j.transproceed.2009.06.055","DOI":"10.1016\/j.transproceed.2009.06.055"},{"key":"4558_CR25","doi-asserted-by":"crossref","unstructured":"Guerra R, Auyanet I, Fern\u00e1ndez EJ, P\u00e9rez MA, Bosch E, Ramirez A, Suria S, Checa MD (2011) Hypercalcemia secondary to persistent hyperparathyroidism in kidney transplant patients: analysis after a year with cinacalcet. J Nephrol 24:78\u201382","DOI":"10.5301\/JN.2010.293"},{"key":"4558_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.5414\/CNP74433","volume":"74","author":"J Aalten","year":"2010","unstructured":"Aalten J, Wetzels JFM, Hoitsma AJ (2010) Continuation of cinacalcet immediately after renal transplantation: a prospective cohort study. Clin Nephrol 74:433\u2013439","journal-title":"Clin Nephrol"},{"key":"4558_CR27","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/TP.0b013e3182079431","volume":"91","author":"A Schwarz","year":"2011","unstructured":"Schwarz A, Merkel S, Leitolf H, Haller H (2011) The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism. Transplantation 91:560\u2013565. https:\/\/doi.org\/10.1097\/TP.0b013e3182079431","journal-title":"Transplantation"},{"key":"4558_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5414\/CNP75263","volume":"75","author":"LRS Pinho","year":"2011","unstructured":"Pinho LRS, Ribeiro Santos MJC, Pestana Vasconcelos M (2011) Cinacalcet in the treatment of persistent hyperparathyroidism after kidney transplantation. Clin Nephrol 75:263\u2013268","journal-title":"Clin Nephrol"},{"key":"4558_CR29","doi-asserted-by":"publisher","unstructured":"Boulanger H, Haymann J-P, Fouqueray B, Mansouri R, Metivier F, Mercadal L, Attaf D, Flamant M, Glotz D (2012) Cinacalcet impact on calcium homeostasis and bone remodeling in 13 renal transplanted patients with hyperparathyroidism and hypercalcaemia. Nephrol Ther 8:47\u201353. https:\/\/doi.org\/10.1016\/j.nephro.2011.04.007","DOI":"10.1016\/j.nephro.2011.04.007"},{"key":"4558_CR30","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1097\/TP.0b013e31822d87e8","volume":"92","author":"E Zitt","year":"2011","unstructured":"Zitt E, Woess E, Mayer G, Lhotta K (2011) Effect of cinacalcet on renal electrolyte handling and systemic arterial blood pressure in kidney transplant patients with persistent hyperparathyroidism. Transplantation 92:883\u2013889. https:\/\/doi.org\/10.1097\/TP.0b013e31822d87e8","journal-title":"Transplantation"},{"key":"4558_CR31","doi-asserted-by":"publisher","unstructured":"Evenepoel P, Sprangers B, Lerut E, Bammens B, Claes K, Kuypers, Meijers B, Varenterghem Y (2012) Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study. Clin Transpl 26:393\u2013402. https:\/\/doi.org\/10.1111\/j.1399-0012.2011.01524.x","DOI":"10.1111\/j.1399-0012.2011.01524.x"},{"key":"4558_CR32","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1097\/TP.0b013e31826c3968","volume":"94","author":"JB Cohen","year":"2012","unstructured":"Cohen JB, Gordon CE, Balk EM, Francis JM (2012) Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis. Transplantation 94:1041\u20131048. https:\/\/doi.org\/10.1097\/TP.0b013e31826c3968","journal-title":"Transplantation"},{"key":"4558_CR33","doi-asserted-by":"publisher","unstructured":"Evenepoel P, Cooper K, Holdaas H, Messa P, Mourad G, Olgaard K, Ruthkowski B, Schaefer H, Deng H, Torregrosa JV, Wuthrich RP, Yue S (2014) A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism. Am J Transplant 14:2545\u20132555. https:\/\/doi.org\/10.1111\/ajt.12911","DOI":"10.1111\/ajt.12911"},{"key":"4558_CR34","doi-asserted-by":"publisher","first-page":"292654","DOI":"10.1155\/2015\/292654","volume":"2015","author":"U Thiem","year":"2015","unstructured":"Thiem U, Gessl A, Borchhardt K (2015) Long-term clinical practice experience with cinacalcet for treatment of hypercalcemic hyperparathyroidism after kidney transplantation. Biomed Res Int 2015:292654. https:\/\/doi.org\/10.1155\/2015\/292654","journal-title":"Biomed Res Int"},{"key":"4558_CR35","doi-asserted-by":"crossref","unstructured":"Cruzado JM, Moreno P, Torregrosa JV, Taco O, Mast R, Gomez-Vaquero C, Polo C, Revuelta I, Francos J, Torras J Garcia-Barrasa A, Bestard O, Grinyo JM (2016) A Randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. - PubMed - NCBI. https:\/\/www-ncbi-nlm-nih-gov.gate2.inist.fr\/pubmed\/26647424. Accessed 28 Sep 2018","DOI":"10.1681\/ASN.2015060622"},{"key":"4558_CR36","doi-asserted-by":"publisher","unstructured":"Zavvos V, Fyssa L, Papasotiriou M, Papachristou E, Ntrinias T, Savviadaki E, Goumenos DS (2018) Long-term use of cinacalcet in kidney transplant recipients with hypercalcemic secondary hyperparathyroidism: a single-center prospective study. Exp Clin Transplant 16:287\u2013293. https:\/\/doi.org\/10.6002\/ect.2016.0342","DOI":"10.6002\/ect.2016.0342"},{"key":"4558_CR37","doi-asserted-by":"publisher","unstructured":"Borchhardt KA, Diarra D, Sulzbacher I, Benesch T, Haas M, Sunder-Plassmann G (2010) Cinacalcet decreases bone formation rate in hypercalcemic hyperparathyroidism after kidney transplantation. Am J Nephrol 31:482\u2013489. https:\/\/doi.org\/10.1159\/000304180","DOI":"10.1159\/000304180"},{"key":"4558_CR38","doi-asserted-by":"publisher","unstructured":"Borstnar S, Erzen B, Gmeiner Stopar T, Kocjan T, Arnol M, Kandus D, Kovac D (2010) Treatment of hyperparathyroidism with cinacalcet in kidney transplant recipients. Transplant Proc 42:4078\u20134082. https:\/\/doi.org\/10.1016\/j.transproceed.2010.09.059","DOI":"10.1016\/j.transproceed.2010.09.059"},{"key":"4558_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000323902","volume":"34","author":"J Henschkowski","year":"2011","unstructured":"Henschkowski J, Bischoff-Ferrari HA, W\u00fcthrich RP, Serra AL (2011) Renal function in patients treated with cinacalcet for persistent hyperparathyroidism after kidney transplantation. Kidney Blood Press Res 34:97\u2013103. https:\/\/doi.org\/10.1159\/000323902","journal-title":"Kidney Blood Press Res"},{"key":"4558_CR40","doi-asserted-by":"publisher","unstructured":"Niel O, Maisin A, Macher M-A, Peuchmaur M, Desch\u00eanes G (2016) Cinacalcet in hyperparathyroidism management after pediatric renal transplantation. CEN Case Rep 5:141\u2013143. https:\/\/doi.org\/10.1007\/s13730-015-0211-0","DOI":"10.1007\/s13730-015-0211-0"},{"key":"4558_CR41","doi-asserted-by":"publisher","unstructured":"Plotnicki L, Kohl CD, H\u00f6cker B, Krupka K, Rahmel A, Pape L, Hoyer P, Marks SD, Webb NJA, S\u00f6ylemezoglu O, Topaloglu R, Szabo AJ, Seeman T, Marlies Cornelissen EA, Knops N, Grenda R, T\u00f6nshoff B (2013) The CERTAIN Registry: a novel, web-based registry and research platform for pediatric renal transplantation in Europe. Transplant Proc 45:1414\u20131417. https:\/\/doi.org\/10.1016\/j.transproceed.2013.01.007","DOI":"10.1016\/j.transproceed.2013.01.007"},{"key":"4558_CR42","unstructured":"K\u00f6ster L, Krupka K, H\u00f6cker B, Rahmel A, Samuel U, Zanen W, Opelz G, S\u00fcsal C, D\u00f6hler B, Plotnicki L, Kohl CD, Knaup P, T\u00f6nshoff B (2015) Integrating data from multiple sources for data completeness in a web-based registry for pediatric renal transplantation--the CERTAIN Registry. Stud Health Technol Inform 216:1049"},{"key":"4558_CR43","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2215\/CJN.01640309","volume":"4","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4:1832\u20131843. https:\/\/doi.org\/10.2215\/CJN.01640309","journal-title":"Clin J Am Soc Nephrol"},{"key":"4558_CR44","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/ki.2011.336","volume":"80","author":"S Habbig","year":"2011","unstructured":"Habbig S, Beck BB, Hoppe B (2011) Nephrocalcinosis and urolithiasis in children. Kidney Int 80:1278\u20131291. https:\/\/doi.org\/10.1038\/ki.2011.336","journal-title":"Kidney Int"},{"key":"4558_CR45","doi-asserted-by":"publisher","unstructured":"Nanmoku K, Shinzato T, Kubo T, Shimizu T, Yagisawa T (2019) Prevalence and predictors of early hypercalcemia after kidney transplantation: a nested case\u2013control study within a cohort of 100 patients. Clin Exp Nephrol 23:268\u2013274. https:\/\/doi.org\/10.1007\/s10157-018-1627-6","DOI":"10.1007\/s10157-018-1627-6"},{"key":"4558_CR46","doi-asserted-by":"publisher","first-page":"294","DOI":"10.6002\/ect.2014.0157","volume":"14","author":"K Gulleroglu","year":"2016","unstructured":"Gulleroglu K, Baskin E, Moray G, Haberal M (2016) Low-grade persistent hyperparathyroidism after pediatric renal transplant. Exp Clin Transplant 14:294\u2013298. https:\/\/doi.org\/10.6002\/ect.2014.0157","journal-title":"Exp Clin Transplant"},{"key":"4558_CR47","doi-asserted-by":"publisher","first-page":"e13238","DOI":"10.1111\/petr.13238","volume":"22","author":"DH Kim","year":"2018","unstructured":"Kim DH, Lee JH, Han DJ, Park YS (2018) Risk factors for persistent hyperparathyroidism in children with stable renal function after kidney transplantation. Pediatr Transplant 22:e13238. https:\/\/doi.org\/10.1111\/petr.13238","journal-title":"Pediatr Transplant"},{"key":"4558_CR48","doi-asserted-by":"publisher","unstructured":"Wesseling-Perry K, Pereira RC, Tsai E, Ettenger R, J\u00fcppner H, Salusky IB (2013) FGF23 and mineral metabolism in the early post-renal transplantation period. Pediatr Nephrol 28:2207\u20132215. https:\/\/doi.org\/10.1007\/s00467-013-2547-z","DOI":"10.1007\/s00467-013-2547-z"},{"key":"4558_CR49","doi-asserted-by":"publisher","unstructured":"Warady BA, Iles JN, Ariceta G, Dehmel B, Hidalgo G, Jiang X, Laskin B, Shahinfar S, Vande Walle J, Schaefer F (2019) A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis. Pediatr Nephrol 34:475\u2013486. https:\/\/doi.org\/10.1007\/s00467-018-4116-y","DOI":"10.1007\/s00467-018-4116-y"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04558-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-020-04558-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04558-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:02:09Z","timestamp":1620086529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-020-04558-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["4558"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04558-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,4]]},"assertion":[{"value":"11 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"For research purposes, an analysis of the multinational dataset requires approval of the predefined study protocol by the CERTAIN Registry Steering Committee. Written informed consent was obtained from all parents\/guardians to participate in the registry, with assent from patients as appropriate for their age. The CERTAIN Registry has been approved by the ethics committee of each contributing center and is kept in full accordance with the principles of the Declaration of Helsinki and Good Clinical Practice guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}